• Mashup Score: 1
    Review of Ophthalmology – Monthly Publication for Ophthalmologists - 2 year(s) ago

    Review of Ophthalmology highlights current, clinically relevant information on surgical techniques, disease diagnosis and management and new technologies

    Source: reviewofophthalmology.com
    Categories: Latest Headlines, Ophthalmology
    Tweet Tweets with this article
    • Profile photo of RevOphth
      RevOphth

      Our team spent the last few days at #ASCRS2022 and had the pleasure of listening to dozens of excellent presentations by many brilliant doctors and eye surgeons. Thank you to all who came and contributed to another great #ASCRS meeting!👏 https://t.co/b4Bv3x1hZt #ophthalmology https://t.co/iiZkdPRrin

  • Mashup Score: 1
    Tonometer DIATON Eye Tonometer - IOP through Eyelid & Sclera Tonometry - 2 year(s) ago

    Unique Tonometer DIATON® Measures IOP THROUGH Eyelid and Sclera (ZERO contact with eyeball ) Quick, Puff-free & Painless (Perfect for children and squeamish adults) Safe: No Risk of infecting or scratching cornea (safer vs other methods) No need for Sterilization or Disinfection (contact only with eyelid. Meets and Exceeds Joint Commission Stalinization and Disinfection Standards)

    Source: Tonometer Diaton
    Categories: Latest Headlines, Ophthalmology
    Tweet Tweets with this article
    • Profile photo of GLAUCOMA
      GLAUCOMA

      RT @TONOMETER: Team #Diaton at #ASCRS #ASOA ANNUAL MEETING IN WASHINGTON, DC. SEE WHAT WE'VE BEEN UP TO https://t.co/LGm9aYOiWo #IOP TR…

  • Mashup Score: 1
    Orasis phase 2b data for CSF-1 presented at ASCRS - 2 year(s) ago

    For the first time, Orasis Pharmaceutical’s phase 2b data for the company’s novel candidate for the treatment of presbyopia, CSF-1, a preservative-free solution that contains a proprietary combination of low-dose pilocarpine and multi-faceted vehicle, will be presented during ASCRS by Marjan Farid, MD, and Preeya Gupta, MD. The company recently released its phase 3 topline results. Orasis’ Paul…

    Source: Ophthalmology Times
    Categories: Latest Headlines, Ophthalmology
    Tweet Tweets with this article
    • Profile photo of OphthTimes
      OphthTimes

      NEWS: @OrasisPharma phase 2b data for CSF-1 presented at #ASCRS WATCH here: https://t.co/3qaQLxXhK3 #Ophthalmology #ASCRS2022 #Clinical #Presbyopia https://t.co/J0AvIzReQ0

  • Mashup Score: 0
    Top ONE Network videos of 2021 - 2 year(s) ago

    From facial swelling following the COVID-19 vaccine to a new approach to iridodialysis repair, here’s a look at the year’s most popular 1-Minute videos, clinical/surgical videos, and interviews.

    Source: American Academy of Ophthalmology
    Categories: Latest Headlines, Ophthalmology
    Tweet Tweets with this article
    • Profile photo of aao_ophth
      aao_ophth

      See the most-watched #ONENetwork videos of 2021. https://t.co/lcXl2mEM8Y #COVID #clined #surgicalvideos #aaoyo #cataract #cornea #retina #pediatrics #glaucoma #oculoplastics #neuro #aao2021 #ascrs

  • Mashup Score: 0
    Grail Study shows refractive stability of Juvene IOL - 3 year(s) ago

    Eric Donnenfeld, MD, presents results of the year-long Grail Study demonstrating the safety and performance of the Juvene IOL from LensGen Inc.

    Source: Ophthalmology Times
    Categories: Latest Headlines, Ophthalmology
    Tweet Tweets with this article
    • Profile photo of OphthTimes
      OphthTimes

      . @DonnenfeldEric presents results of the year-long Grail Study demonstrating the safety and performance of the Juvene #IOL from LensGen Inc. https://t.co/QkRRH0VyFN #Ophthalmology #ASCRS #Cataract #Refractive #ASCRS2021

  • Mashup Score: 2
    RVL Pharmaceuticals: Shifting toward ocular aesthetics - 3 year(s) ago

    COO JD Schaub provides an overview of how RVL Pharmaceuticals has shifted toward becoming an ocular aesthetics company, with the sole purpose to fully focus on UPNEEQ®.

    Source: Ophthalmology Times
    Categories: Latest Headlines, Ophthalmology
    Tweet Tweets with this article
    • Profile photo of OphthTimes
      OphthTimes

      WATCH: JD Schaub discusses how RVL Pharmaceuticals has shifted toward becoming an ocular aesthetics company, with the sole purpose to fully focus on UPNEEQ®. See the full interview: https://t.co/MMp71rgRpk #ASCRS #ASCRS2021 #RVL #Ophthalmology #Ocular https://t.co/MSClNOsaGl

  • Mashup Score: 3
    ViaLase CEO talks innovations in glaucoma treatment - 3 year(s) ago

    Tibor Juhasz, CEO of ViaLase, Inc, discusses the company’s development of a novel, noninvasive high-resolution OCT image-guided femtosecond laser technology for the treatment of open-angle glaucoma.

    Source: Ophthalmology Times
    Categories: Latest Headlines, Ophthalmology
    Tweet Tweets with this article
    • Profile photo of OphthTimes
      OphthTimes

      WATCH: Tibor Juhasz, CEO of ViaLase, Inc, discusses the company's development of a novel, noninvasive high-resolution #OCT image-guided femtosecond laser technology for the treatment of #glaucoma. https://t.co/l56lPOcDjg #Ophthalmology #ASCRS #ASCRS2021 #ViaLase https://t.co/92TWwvZZIK

Load More